Inhibikase Therapeutics (IKT) Price to Book (2020 - 2026)
Inhibikase Therapeutics' Price to Book came in at 2.31 for Q2 2026, up 27.3% from 1.82 a year earlier and up 33.8% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Price to Book (2020 - 2026) Analysis & Trends
For FY2025, Inhibikase Therapeutics' Price to Book was 1.17, up 43.5% from FY2024.
- Price to Book has increased in each of the last three years.
- Going back by year, Price to Book was 0.81 in FY2024 (+13.5%), 0.72 in FY2023 (+19.3%), 0.60 in FY2022 (-13.9%) and 0.70 in FY2021 (-88.0%).
- The Q2 2026 figure represents the highest quarterly Price to Book since Q1 2021.
- Year-over-year, Price to Book increased in four of the last six quarters, with growth averaging 12.2%.
- The fastest year-over-year change in Price to Book over five years came in Q1 2024 (growth of 155.3%), and the weakest in Q4 2021 (a decline of 88.0%).
- Business Quant data shows IKT's Price to Book at 1.73 (Q1 2026), 1.17 (Q4 2025) and 1.66 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Inhibikase Therapeutics | 336.92 Mn | -248.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 |
| Mar 31, 2026 | 1.73 |
| Dec 31, 2025 | 1.17 |
| Sep 30, 2025 | 1.66 |
| Jun 30, 2025 | 1.82 |
| Mar 31, 2025 | 1.90 |
| Dec 31, 2024 | 0.81 |
| Jun 30, 2024 | 1.71 |
| Mar 31, 2024 | 2.06 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.98 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.91 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 1.10 |
| Dec 31, 2021 | 0.70 |
| Sep 30, 2021 | 1.11 |
| Jun 30, 2021 | 0.73 |
API Access
Inhibikase Therapeutics Price to Book API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-book&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-book", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-book&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();